Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Next Generation Sequencing Facilitates Quantitative Analysis of CP5322-treated and Non-treated Transcriptomes in Kasumi-1 cells

ABSTRACT: Next Generation Sequencing Facilitates Quantitative Analysis of CP5322-treated and Non-treated Transcriptomes in Kasumi-1 cells

PROVIDER: PRJNA597464 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10763402_1.fastq.gz	Fastqsanger.gz
	SRR10763402_2.fastq.gz	Fastqsanger.gz
	SRR10763403_1.fastq.gz	Fastqsanger.gz
	SRR10763403_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Next Generation Sequencing Quantitative Analysis of 0.5% BSA and IL10 treated Kasumi-1 cells' Transcriptomes

Project description:Examination the gene expression profile changes of Kasumi-1 cells treated with rhIL10.

2021-09-30 | GSE158721 | GEO

Next Generation Sequencing Facilitates Quantitative Analysis of CP5322-treated and Non-treated Transcriptomes in Kasumi-1 cells

Project description:Purpose: The goals of this study are designed to study the alteration of transcriptome profiling (RNA-seq) in CP5322-treated and non-treated cells. The drug was a herbal small molecular, which was designed as a HDAC inhibitor, called CP5322. TK1 was the group of CP5322-treated, and CK1 was the group of control. Methods: The mRNA profiles of drug-treated and non-treated cells were generated by next genenration sequencing, using Illumina platform. The clustering of the index-coded samples was performed on a cBot cluster generation system using HiSeq PE Cluster Kit v4-cBot-HS (Illumina) according to the manufacturer's instructions. After cluster generation, the libraries were sequenced on an Illumina platform and 150 bp paired-end reads were generated, which was called Raw Reads. And the low quality sequences and adaptor contamination were removed.Data processing was completed to obtain high-quality sequences (Clean Reads), and all subsequent analyses were based on Clean Reads. Results: Using the data analysis workflow, we mapped about 46 million sequence reads per sample to the human genome (h19) and identified 23 thousand transcripts in the drug-treated and non-treated cells. And the mapping rate was about 97%. RNA-seq data showed a significant alteration when the Kasumi-1 cells were treated by drug. Conclusions: The RNA-Seq data provided us a priori evidence for further research.

2020-03-01 | GSE142561 | GEO

Next Generation Sequencing Quantitative Analysis of 0.5% BSA and IL10 treated Kasumi-1 cells' Transcriptomes

Project description:Next Generation Sequencing Quantitative Analysis of 0.5% BSA and IL10 treated Kasumi-1 cells' Transcriptomes

| PRJNA666352 | ENA

Next Generation Sequencing Facilitates Quantitative Analysis of LPS treated THP-1 cells' Transcriptomes

Project description:Next Generation Sequencing Facilitates Quantitative Analysis of LPS treated THP-1 cells' Transcriptomes

| PRJNA779446 | ENA

Next Generation Sequencing Facilitates Quantitative Analysis of HaCaT and OSM-treated HaCaT Transcriptomes

Project description:Next Generation Sequencing Facilitates Quantitative Analysis of HaCaT and OSM-treated HaCaT Transcriptomes

| PRJNA634341 | ENA

mRNA expression quantitative Analysis of Kasumi-1 treated with I3 compared with control

Project description:The goals of this study are toevaluate the mRNA expressions of genes in Kasumi-1 cell lines treated with I13

2022-09-16 | GSE193969 | GEO

mRNA expression quantitative Analysis of Kasumi-1 treated with I1 compared with control

Project description:The goals of this study are toevaluate the mRNA expressions of genes in Kasumi-1 cell lines treated with I13

2022-12-31 | GSE193971 | GEO

mRNA expression quantitative Analysis of Kasumi-1 treated with I13 compared with control

Project description:The goals of this study are toevaluate the mRNA expressions of genes in Kasumi-1 cell lines treated with I13

2022-05-05 | GSE193964 | GEO

Next Generation Sequencing Facilitates Quantitative Analysis of Solanum lycopersicum bud and flower Transcriptomes

Project description:Next Generation Sequencing Facilitates Quantitative Analysis of Solanum lycopersicum bud and flower Transcriptomes

2021-02-27 | GSE164382 | GEO

Next Generation Sequencing Facilitates Quantitative Analysis of Vehicle Control and Vismodegib Treated Tumor Transcriptomes

Project description:Next Generation Sequencing Facilitates Quantitative Analysis of Vehicle Control and Vismodegib Treated Tumor Transcriptomes

| PRJNA609731 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data